Investing is one of the best methods for building your wealth for retirement.
You can choose to park your money in growth stocks that lift the value of your portfolio, or dividend stocks that pay out regular passive income.
When looking for growth, a key metric to look at is whether the business has increased its profits.
A company that can consistently increase its profits should enjoy a higher share price over time, netting investors attractive capital gains.
Here are five Singapore stocks that announced higher profits during the recent earnings season.
Soup Holdings (SGX: 5KI)
Soup Holdings operates a chain of restaurant outlets under the name of “Soup Restaurant” in Singapore.
The group owns other brands such as Tea House by Soup Restaurant and Café O.
For the first half of 2025 (1H 2025), revenue dipped 6.3% year on year to S$19.4 million.
Net profit, however, climbed 34.1% year on year to S$224,000.
The restaurant chain also churned out a positive free cash flow of S$2.2 million, 10% higher than a year ago.
Although management warned of fierce competition from new entrants into the food and beverage scene, the group will take proactive steps to fortify the business by refreshing its brand.
It will also streamline operations and procurement to manage costs and introduce digital solutions to boost customer engagement.
Raffles Medical Group (SGX: BSL)
Raffles Medical Group, or RMG, is an integrated private healthcare provider offering a comprehensive range of services, ranging from primary to tertiary healthcare.
The group’s network comprises four hospitals and over 100 multi-disciplinary clinics.
For 1H 2025, revenue inched up 3.5% year on year to S$378.4 million.
Operating profit crept up 0.8% year on year to S$41.6 million while net profit increased 4.8% year on year to S$32.1 million.
The group’s China hospitals saw revenue increase marginally in RMB terms, and the Raffles brand has also gained wider acceptance and recognition among patients in China.
In terms of business developments, RMG forged two strategic partnerships with Shanghai’s Renji Hospital and Chongqing’s First Affiliated Hospital to establish a new model for medical cooperation between Singapore and China.
By integrating international standards with Chinese local expertise, the healthcare group can drive medical innovation and raise the overall quality of care, thereby attracting more patients through its doors.
Indofood Agri (SGX: 5JS)
Indofood Agri has a vertically integrated agribusiness model that spans the entire value chain from oilseed breeding, oil palm cultivation, to milling and refining.
The group also engages in the cultivation of rubber, sugar cane, and other crops.
Revenue for 1H 2025 jumped 33.2% year on year to IDR 9.4 trillion.
Operating profit increased by 12.8% year on year to IDR 1.2 trillion.
Net profit improved by 13.4% year on year to IDR 337.8 billion.
The higher revenue was attributed to a higher average selling price of palm products, along with higher sales volume of palm products.
Indofood Agri’s core net profit, which strips out changes in biological assets, soared 87% year on year to IDR 945 billion.
The group is expanding its Tanjung Priok refinery by 450,000 metric tonnes (MT) per year in 2H 2025.
This will increase the crude palm oil (CPO) refining capacity from 1.7 MT to 2.2 MT per year.
Sheng Siong (SGX: OV8)
Sheng Siong operates one of the largest supermarket chains in Singapore and has 82 outlets around the island as of the end of July 2025.
The group offers over 1,750 products under 25 house brands, ranging from food products to paper goods.
For 1H 2025, revenue rose 7.1% year on year to S$764.7 million while gross profit improved by 9.6% year on year to S$235.6 million.
The retailer’s gross margin increased from 30.1% in the previous corresponding period to 30.8%.
Net profit stood at S$72.3 million, 3.4% higher than a year ago.
An interim dividend of S$0.032 was declared, unchanged from the previous year.
The supermarket operator opened five new stores in 1H 2025 and two more in July this year.
One more new store is expected to open in 3Q 2025, taking the total opened to year-to-date to eight stores.
Three HDB tenders are awaiting results, and management expects three more HDB stores to be released for tender by June 2026.
Samudera Shipping Line (SGX: S56)
Samudera is engaged in the transportation of containerised and non-containerised cargo.
The group’s vessels ply trade routes connecting ports in Southeast Asia, the Far East, and the Middle East.
For 1H 2025, revenue increased by 28% year on year to US$285.5 million.
Operating profit more than doubled year on year to US$42.2 million while net profit doubled from US$20.9 million to US$41.8 million.
The shipping company also saw its free cash flow soar more than sixfold year on year to US$58.9 million.
An interim dividend of S$0.015 was declared, 50% higher than the S$0.01 paid out last year.
The group’s logistics business is expected to do well, supported by the fourth-party logistics business.
Management sees opportunities to grow this division by leveraging its track record and taking advantage of the growing demand for such services in Indonesia.
Singapore’s stock market is on a historic run, but can it last? We’ll explore where interest rates are heading, whether blue-chip earnings can keep growing and more.
Get the clarity you need — sign up now for our free webinar.
Imagine a life where steady income flows, no matter the market. Our new free report, “Retire Early with Dividends,” reveals how. We’ve pinpointed 5 dependable Singapore dividend stocks that offer a proven, stress-free path to financial freedom. Stop just dreaming and start building your early retirement plan today. Your free guide awaits here.
Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses!
Disclosure: Royston Yang owns shares of Raffles Medical Group.
